12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Primary invasive cutaneous aspergillosis is a rare fungal infection that occurs mostly in immunocompromised patients. Newborns of very low birth weight present a high risk for this type of infection due to an immaturity of the cutaneous barrier and of the immune system.

          Case presentation

          We describe here a case of simultaneous invasive cutaneous aspergillosis in two preterm twins. Two male preterm bichorionic biamniotic twins (A & B) were born at a general hospital by spontaneous normal delivery at 24 weeks and 6 days of gestation. They were transferred to our hospital where they receive surfactant, antibiotics and hydrocortisone. Six days later, twin A showed greenish lesions in the umbilical region. The spectrum of antibiotic therapy was broadened and fluconazole was added. The umbilical catheters of the two twins were removed and replaced by epicutaneo-cava venous catheters and the cultures were positive for Aspergillus fumigatus. Fluconazole was replaced in both twins by liposomal amphotericin B and the incubators were changed. The serum galactomannan was also positive for both twins. At day 10, yellowish lesions appeared in the abdominal region in twin B. He died on day 18 following complications related to his prematurity. Concerning the twin A, serum galactomannan was negative on day 30; liposomal amphotericin B was stopped 1 week later, with a relay by econazole (cream). His condition improved and on day 66 he was transferred for follow-up at the general hospital where he was born.

          Conclusion

          The source of contamination by A. fumigatus was not identified, but other similar cases from the literature include construction work at or near the hospital, oximeter sensors, latex finger stalls, non-sterile gloves, humidifying chambers of incubators, bedding and adhesive tapes. The skin fragility of preterm newborns is an excellent potential entry point for environmental fungal infections. These cases highlight the importance of suspecting primary cutaneous aspergillosis in extremely low birth weight neonates with rapidly progressive necrotic lesions.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: not found
          • Article: not found

          Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.

            Bronchopulmonary dysplasia, a major complication of extreme prematurity, has few treatment options. Postnatal steroid use is controversial, but low-dose hydrocortisone might prevent the harmful effects of inflammation on the developing lung. In this study, we aimed to assess whether low-dose hydrocortisone improved survival without bronchopulmonary dysplasia in extremely preterm infants.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

              By comparing natural immunity to Aspergillus fumigatus (AF) in vivo with the action of human or mouse phagocytes against AF in vitro, we delineated two sequential lines of defense against AF. The first line of defense was formed by macrophages and directed against spores. Macrophages prevented germination and killed spores in vitro and rapidly eradicated conidia in vivo, even in neutropenic and athymic mice. The second was the neutrophilic granulocyte (PMN), which protected against the hyphal form of AF. Human and mouse PMN killed mycelia in vitro. Normal, but not neutropenic mice, stopped hyphal growth, and eradicated mycelia. Either line of defense acting alone protected mice from high challenge doses. Natural immunity collapsed only when both the reticuloendothelial system and PMN were impaired. These findings are in keeping with the clinical observation that high doses of cortisone and neutropenia are the main risk factors for invasive aspergillosis. Cortisone inhibited the conidiacidal activity of mouse macrophages in vivo and of human or mouse mononuclear phagocytes in vitro. Cortisone damaged this first line of defense directly and not through the influence of T lymphocytes or other systems modifying macrophage function as shown in athymic mice and in vitro. In addition, daily high doses of cortisone in mice reduced the mobilization of PMN so that the second line of defense was also impaired. Thus, cortisone can break down natural resistance on its own. Myelosuppression rendered mice susceptible only when the first line of defense was overpowered by high challenge doses, by activated spores that cannot be killed by macrophages, or by cortisone suppression of the conidiacidal activity of macrophages. The host, thus, can call upon two independent phagocytic cell lines that form graded defense systems against aspergillus. These lines of defense function in the absence of a specific immune response, which seems superfluous in the control and elimination of this fungus.
                Bookmark

                Author and article information

                Contributors
                floriane.gallais@chru-strasbourg.fr
                julie.denis@chru-strasbourg.fr
                olfakoobar@gmail.com
                laurence.palpacuer@chru-strasbourg.fr
                Dominique.Astruc@chru-strasbourg.fr
                Raoul.Herbrecht@chru-strasbourg.fr
                candolfi@unistra.fr
                letscher@unistra.fr
                amsabou@unistra.fr
                Journal
                BMC Infect Dis
                BMC Infect. Dis
                BMC Infectious Diseases
                BioMed Central (London )
                1471-2334
                2 August 2017
                2 August 2017
                2017
                : 17
                : 535
                Affiliations
                [1 ]Laboratoire de Parasitologie et de Mycologie Médicale, Plateau Technique de Microbiologie ; Hôpitaux Universitaires de Strasbourg. 1 Place de l’Hôpital, F-67000 Strasbourg, France
                [2 ]ISNI 0000 0001 2157 9291, GRID grid.11843.3f, , Université de Strasbourg, Institut de Parasitologie et de Pathologie Tropicale, DIHP EA 7292, Fédération de Médecine Translationnelle, ; 3 rue Koeberlé, F-67000 Strasbourg, France
                [3 ]ISNI 0000 0004 0593 6932, GRID grid.412201.4, , Service de Réanimation Néonatale, Hôpital de Hautepierre ; Hôpitaux Universitaires de Strasbourg, ; Avenue Molière, F-67200 Strasbourg, France
                [4 ]ISNI 0000 0004 0593 6932, GRID grid.412201.4, , Service d’Oncologie et d’Hématologie, Hôpital de Hautepierre ; Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, ; Strasbourg, France
                Article
                2646
                10.1186/s12879-017-2646-8
                5541690
                28768499
                6f162d55-327d-4013-898d-53985120e183
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 27 January 2017
                : 27 July 2017
                Categories
                Case Report
                Custom metadata
                © The Author(s) 2017

                Infectious disease & Microbiology
                primary cutaneous aspergillosis,newborn,aspergillus,a. fumigatus,preterm,premature,invasive aspergillosis

                Comments

                Comment on this article